Medical device maker Boston Scientific forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted ...

A ureteral stent is a flexible plastic tube for insertion into the ureter to treat or prevent blockages that impede urine flow from the kidney to the bladder, such as kidney stones. Once the ...

Expert Rev Gastroenterol Hepatol. 2012;6(1):105-114. When double-stent placement (duodenal and biliary) is considered, biliary stent placement can be performed either preceding or following ...

Continuing its acquisition streak into 2025, Marlborough-based medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire California-based medical equipment ...

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against the other stocks. Ten companies--predominantly gold miners--led Wednesday's rally on Wall ...

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake. Boston ...